Abstract

Macrophages are a significant source of lipoprotein lipase (LPL) and apolipoprotein E (apo E) in the developing arterial wall lesion, and each of these proteins can importantly modulate lipid and lipoprotein metabolism by arterial wall cells. LPL and apo E share a number of cell surface binding sites, including proteoglycans, and we have previously shown that proteoglycans are important for modulating net secretion of apoprotein E from macrophages. We therefore evaluated a potential role for LPL in modulating net secretion of macrophage-derived apo E. In pulse-chase experiments, addition of LPL during the chase period produced a decrease in secretion of apoprotein E from human monocyte-derived macrophages, from the human monocytic THP1 cell line, and from J774 cells transfected to constitutively express a human apo E cDNA. LPL similarly reduced apo E secretion when it was prebound to the macrophage cell surface at 4 degrees C. A native LPL particle was required to modulate apo E secretion; addition of monomers and aggregates did not produce the same effect. Depletion of cell surface proteoglycans by a 72-h incubation in 4-methylumbelliferyl-beta-D-xyloside did not attenuate the ability of LPL to reduce apo E secretion. However, addition of receptor-associated protein attenuated the effect of LPL on apo E secretion. Although LPL could mediate removal of exogenously added apo E from the culture medium, detailed pulse-chase analysis suggested that it primarily prevented release of newly synthesized apo E from the cell layer. Cholesterol loading of cells or antibodies to the low density lipoprotein receptor attenuated LPL effects on apo E secretion. We postulate that LPL sequesters endogenously synthesized apo E at the cell surface by a low density lipoprotein receptor-dependent mechanism. Such post-translational regulation of macrophage apo E secretion by LPL could significantly influence apo E accumulation in arterial vessel wall lesions.

Highlights

  • Macrophages are a significant source of lipoprotein lipase (LPL) and apolipoprotein E in the developing arterial wall lesion, and each of these proteins can importantly modulate lipid and lipoprotein metabolism by arterial wall cells

  • LPL and apolipoprotein E (apo E) share a number of cell surface binding sites, including proteoglycans, and we have previously shown that proteoglycans are important for modulating net secretion of apoprotein E from macrophages

  • The data presented indicate that native LPL reduces the secretion of newly synthesized apo E in the macrophage in an LDLR-dependent manner

Read more

Summary

Lipoprotein Lipase Reduces Secretion of Apolipoprotein E from Macrophages*

(Received for publication, July 9, 1996, and in revised form, November 27, 1996). Madhuri Lucas‡, Per-Henrik Iverius§, Dudley K. A substantial portion of the apo E synthesized by the macrophage is retained in the pericellular proteoglycan matrix and is rapidly returned to the cell for degradation [22] In view of this observation and previous reports regarding the interaction between pericellular proteoglycans and LPL, we formally evaluated a role for LPL in modulating the secretion/metabolism of endogenously produced apo E in the macrophage. For these studies, we utilized a macrophage cell model in which apo E is constitutively synthesized and evaluated the effect of exogenously added LPL

EXPERIMENTAL PROCEDURES
Secreted Apo E
RESULTS
Control RAP LPL LPL ϩ RAP
Nonsecreting cells
No cholesterol loading
Control LPL Nonimmune serum ϩ LPL LDLR antiserum ϩ LPL
TABLE VI Polyclonal and monoclonal antibody to LDL receptor inhibits
DISCUSSION
Cholesterol loading of macrophages enhances macrophage
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call